Kidney disease means your kidneys are damaged and can’t filter blood the way they should. Those with diabetes or high blood pressure are at greater risk of developing kidney disease.
Kidney problems include acute kidney injury, chronic kidney disease, kidney cysts, kidney stones, and kidney infections.
Narnygerel Erdenebileg from the State Second Central Hospital in Ulaanbaatar, Mongolia, undertook a three-month ISN Fellowship from June to September 2023 at Johns Hopkins University School of Medicine in Baltimore, USA, under supervision from Mohamed Atta, who is a professor of medicine there. Dr. Erdenebileg wanted to improve her skills in clinical nephrology, kidney biopsy...
We're excited to announce that the complete scientific program for the 2024 World Congress of Nephrology (WCN'24) is now available to explore. Access the program here. This highly anticipated scientific and educational event, the most significant annual, global gathering of kidney experts and professionals, offers a comprehensive insight into the latest developments and breakthroughs in kidney...
Daniel O’Hara, the ISN-ACT Global Trials Focus coordinator, summarizes the design and outcomes of one of the team’s latest trial selections. Read all the latest global trial selections from the ISN-ACT initiative here. The “trial of the month” is available in several languages. Effects of Technology-assisted Stepped Collaborative Care Intervention to Improve Symptoms in Patients Undergoing Hemodialysis:...
Imbalances in electrolyte and acid-base can lead to kidney damage and dysfunction and may indicate underlying kidney diseases and other medical conditions. Regularly monitoring electrolyte and acid-base levels, especially in individuals with kidney disease or other health concerns, is essential to preserve kidney health. ISN members: Access the CME-accredited curriculum here This comprehensive seven-part curriculum delivers a...
The ISN is pleased to share news of its official partnership with the Polycystic Kidney Disease Foundation, a collaboration to raise awareness about polycystic kidney disease and offer educational resources on this rare condition. Together, the two organizations will produce a webinar and podcast. Join us for the upcoming "Equity in ADPKD: Bridging Gaps for Better...
The ISN congratulates and extends a warm welcome to 41 newly matched mentorship pairs in the ISN Mentorship Program. The ISN Mentorship Program facilitates global connections among ISN members to enhance understanding and practice of kidney care in diverse contexts. Mentees achieve professional goals while mentors hone leadership and coaching skills. In the latest application round,...
The Antibody-mediated Injury Working Group of the Banff Foundation on Allograft Pathology invites you to participate in a survey on multidisciplinary transplant meetings. Take the survey here The care of transplant recipients is complex, requiring a collaborative and multidisciplinary effort. Despite evidence supporting the benefits of a multidisciplinary approach in transplantation, the proportion of transplant centers...
From left to right: Caner Alparslan, ISN Young Nephrologists Committee member (Turkey); SWC faculty members Rümeyza Kazancioğlu (Turkey), Hans Peter Marti (Norway), and Zdenka Hruskova (Czech Republic); and host and BANTAO president Mustafa Arici (Turkey)* The ISN held a Scientific Writing Course (SWC) in Istanbul from October 5-7 at Istanbul University's central campus. During the three-day...
The ISN teamed up with the American Society of Diagnostics and Interventional Nephrology to develop a webinar on point-of-care ultrasound (POCUS)-based volume assessment. Watch the webinar here. POCUS, particularly IVC ultrasound, is a valuable tool for assessing intravascular volume, predicting volume responsiveness, and managing conditions like hepatorenal syndrome and congestive organ injury. As technology advances and more...
Kidney International® A Prospective Controlled, Randomized Clinical Trial of Kidney Transplant Recipients Developed Personalized Tacrolimus Dosing Using Model-based Bayesian Prediction In this study, a population pharmacokinetic (PPK) model, incorporating factors such as genetics, age, and hematocrit, was developed and validated to optimize tacrolimus (Tac) dosage for kidney transplant recipients. PPK-based dosing was compared with traditional weight-based dosing....
Delegates at the first edition of the Primer Course in Glomerular Diseases in Tokyo The "Primer Course in Glomerular Diseases" covers best practices in glomerulonephritis management for trainees and early career clinicians. The ISN's first edition of the course took place in Tokyo, Japan, from October 1-2, 2023, held in partnership with the Asian Pacific Society of...
KRACON23 delegates at the onsite ISN booth In September, the ISN supported the Kenya Renal Association and its Annual Conference (KRACON23) in Mombasa, Kenya, through its Educational Ambassador (EA) and Continuing Medical Education Programs. The theme of the event was "Multidisciplinary Approach to Kidney Care." A well-attended gathering The congress saw an impressive turnout of over 500...
To stay updated on the latest research and developments in kidney care, access the latest selection of global trials from the ISN-ACT initiative here in multiple languages. ISN-ACT Global Trials Focus Coordinator Michele Provenzano summarizes the design and outcomes of the ISN-ACT Global Trials Focus’ latest “Trial of the Month.” Balanced Crystalloid Solution Versus Saline in...
The 18th BANTAO (Balkan Cities Association of Nephrology Transplantation and Artificial Organs) Congress combined with the Hellenic Society of Nephrology Meeting and Seminar, endorsed by the ISN, will take place from October 19-22, 2023, in Thessaloniki, Greece. We warmly invite you to visit our ISN booth during the event. We'd love to connect with you...
The 2023 ISN-Global Kidney Health Atlas (ISN-GKHA) is driving positive change in kidney care on a global scale, and you can play a role in this transformation! Assessing global kidney care: ISN-GKHA's comprehensive analysis for informed health policies The ISN-GKHA is a comprehensive resource offering an overview of the current readiness, capacity, and competence for kidney...
In this engaging dialogue, Augusto Cesar Santos Jr. and Peter Kotanko discuss the evolving role of artificial intelligence (AI) in medicine, particularly within kidney care. Listen here They shed light on how AI can serve as a valuable tool for healthcare providers, enabling them to predict patient outcomes, personalize treatment plans and empower patients to take...
Discover the latest addition to the ISN Academy – an exclusive curriculum on rare diseases, with a special focus on complement pathway disorders. This comprehensive course is designed to provide an in-depth understanding of the pathophysiology, diagnosis, and advanced management of complement-mediated kidney diseases. Explore the curriculum here What's included? A seven-module course covering: Comprehensive pathophysiology insights Advanced diagnosis techniques Expert-driven...
The ISN endorses high-quality events for the kidney care community. Whether your event is big or small, it may be eligible for endorsement if it addresses relevant topics in the region. Join us for enhanced visibility, scientific merit, and educational impact. Discover all the benefits of ISN-endorsed meetings and how to apply here. October 4-7 The XV...
Delegates and faculty at the 2ème Cours International de Nephrologie, Dialyse et Transplantation, and 1er Congrès de la Société Congolaise In support of an agreement between the Société Francophone Néphrologie, Dialyse et Transplantation (SFNDT) and the ISN to enhance skills in French-speaking African countries, the ISN Continuing Medical Education Program contributed to the 2ème Cours...
Kidney International® Novel Anemia Therapies in CKD: Conclusions from a KDIGO Controversies Conference The conference, held virtually in December 2021, reviewed new evidence on diagnosing and managing anemia in chronic kidney disease (CKD). The meeting focused on a new class of agents—the hypoxia-inducible factor-prolyl hydroxylase inhibitors (HIF-PHIs). HIF-PHIs are reported to be non-inferior to conventional Erythropoiesis-Stimulating Agents...
